Coronary Artery Disease: Optimal Lipoprotein(a) for Survival—Lower Is Better? A Large Cohort With 43,647 Patients

Background: A high level of lipoprotein(a) can lead to a high risk of cardiovascular events or mortality. However, the association of moderately elevated lipoprotein(a) levels (≥15 mg/dL) with long-term prognosis among patients with coronary artery disease (CAD) is still uncertain. Hence, we aim to...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jin, Liu, Liwei, Wang, Bo, Chen, Shiqun, Liu, Buyun, Liang, Jingjing, Huang, Haozhang, Li, Qiang, Lun, Zhubin, Ying, Ming, Chen, Guanzhong, Huang, Zhidong, Xu, Danyuan, Yan, Xiaoming, Zhu, Tingting, Tadesse, Girmaw Abebe, Tan, Ning, Chen, Jiyan, Liu, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438333/
https://www.ncbi.nlm.nih.gov/pubmed/34532348
http://dx.doi.org/10.3389/fcvm.2021.670859

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438333/
https://www.ncbi.nlm.nih.gov/pubmed/34532348
http://dx.doi.org/10.3389/fcvm.2021.670859

Ejemplares similares